The Virtual Press Room is a courtesy for corporate and institutional public relations professionals. Publication of material on this page does not constitute an endorsement by ASCO of any product or claim. For information about how to submit a press release to the Virtual Press Room, visit the For PR Professionals page.

2023 ASCO Annual Meeting, June 2-6, 2023, Chicago, IL

Day One Biopharmaceuticals
Day One Announces Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Dizal
Dizal’s Rapidly Evolving Oncology Pipeline to Make Waves at 2023 ASCO Meeting
Dizal’s Oncology Pipeline Continues to Impress with Two Oral Presentations at 2023 ASCO Annual Meeting

DukeHealth
Black Men with Metastatic Prostate Cancer May Benefit From Drug Combination

Florida Cancer Specialists & Research Institute
Florida Cancer Specialists & Research Institute Cutting-Edge Clinical Research Presented at 2023 ASCO® Annual Meeting 

Geron
Geron Announces Upcoming Oral Presentation at 2023 American Society of Clinical Oncology Annual Meeting of Imetelstat Data from IMerge Phase 3 Lower Risk MDS Trial

HighField Biopharmaceuticals
HighField Biopharmaceuticals’ HF1K16, a new Immuno-Oncology Drug, Shows Promise in Patients with Refractory Glioblastoma

Immutep Lag-3 Immunotherapy
Immutep Announces Presentation of New TACTI-002 Data at the 2023 ASCO Annual Meeting
Immutep Announces Publication of Abstracts for ASCO 2023 Annual Meeting

Mythic Therapeutics
Mythic Therapeutics Presents Trial in Progress Poster on Investigational cMET-Targeting Antibody-Drug Conjugate (ADC) MYTX-011 at American Society of Clinical Oncology (ASCO) Annual Meeting

Pangaea
Pangaea Data awarded strategic partnership by Mersey Care NHS Foundation Trust and the University of Liverpool’s Mental Health Research for Innovation Centre (M-RIC) to characterize patients across hard-to-diagnose mental health conditions

Penn Medicine
Penn Medicine at the 2023 ASCO Annual Meeting

RWJBarnabas Health
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health Announces Two LateBreaking Presentations at the 2023 ASCO Annual Meeting

Sarah Cannon Research Institute
Sarah Cannon Research Institute to Present Latest Oncology Research Insights at 2023 ASCO® Annual Meeting 

Sunstone Therapies
Sunstone Therapies Presents Data at ASCO Showing Positive Long-Term Follow-up Results from Psilocybin Therapy in Cancer Patients with Major Depressive Disorder (MDD) 

Sylvester Comprehensive Cancer Center at University of Miami Health System
ASCO 23: Global Health Initiative is Ensuring Equitable Cancer Care Beyond South Florida’s Borders
ASCO 23: Thyroid Cancer Precision Approaches That Incorporate Targeted Therapies and Other Treatments Are Changing the Surgeon’s Role 
ASCO 2023 Experts Available